Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F12%3A00059030" target="_blank" >RIV/00216224:14110/12:00059030 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/65269705:_____/12:#0001630
Výsledek na webu
<a href="http://dx.doi.org/10.1016/j.diabres.2011.06.009" target="_blank" >http://dx.doi.org/10.1016/j.diabres.2011.06.009</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.diabres.2011.06.009" target="_blank" >10.1016/j.diabres.2011.06.009</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth
Popis výsledku v původním jazyce
Visfatin is a recently identified adipokine with numerous metabolic and immunoregulatory properties that has been implicated in the regulation of the white adipose tissue (WAT) and significant changes in visfatin levels were reported during pregnancy. The aim of the study was to investigate dynamics of visfatin levels in maternal serum and human breast milk during a 180-d period after the delivery. Breast milk and venous blood samples were obtained from 24 healthy lactating women with uncomplicated, physiological pregnancy and appropriate- for-gestational age neonates and serum?milk sample duos were collected at the time of birth, at the 1?3, 12?14, 28?30, 88?90 and 178?180 postpartum. Our study demonstrates that (1) visfatin is abundantly secreted into breast milk in humans, reaching approx.
Název v anglickém jazyce
Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth
Popis výsledku anglicky
Visfatin is a recently identified adipokine with numerous metabolic and immunoregulatory properties that has been implicated in the regulation of the white adipose tissue (WAT) and significant changes in visfatin levels were reported during pregnancy. The aim of the study was to investigate dynamics of visfatin levels in maternal serum and human breast milk during a 180-d period after the delivery. Breast milk and venous blood samples were obtained from 24 healthy lactating women with uncomplicated, physiological pregnancy and appropriate- for-gestational age neonates and serum?milk sample duos were collected at the time of birth, at the 1?3, 12?14, 28?30, 88?90 and 178?180 postpartum. Our study demonstrates that (1) visfatin is abundantly secreted into breast milk in humans, reaching approx.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FB - Endokrinologie, diabetologie, metabolismus, výživa
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2012
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Diabetes Research and Clinical Practice
ISSN
0168-8227
e-ISSN
—
Svazek periodika
96
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
NL - Nizozemsko
Počet stran výsledku
7
Strana od-do
355-361
Kód UT WoS článku
000305281100024
EID výsledku v databázi Scopus
—